We are live on ! Find out more
AH

Aviva Holdings Portfolio holdings

AUM $20.5M
1-Year Est. Return 117.01%
This Fund
S&P 500
This Quarter Est. Return
+49.38%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$214M
AUM Growth
+$111M
Cap. Flow
+$93.4M
Cap. Flow %
43.54%
Top 10 Hldgs %
100%
Holding
4
New
2
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$175M
2
ESPR
Esperion Therapeutics
ESPR
+$7.79M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$4.87M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
1
DELISTED
Medicines Co
MDCO
$187M 87.42%
+3,833,899
New +$175M
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$15M 6.98%
2,880,702
+888,617
+45% +$4.87M
ESPR
3
DELISTED
Esperion Therapeutics
ESPR
$12M 5.6%
+340,000
New +$7.79M

Similar funds

MFAM
M Financial Asset Management Portland, Oregon $20.6M AUM 4.99% 1-Year Est. Return
SL
Stevard LLC Chicago, Illinois $26.8M AUM 42.43% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CGI
Calixto Global Investors Coral Gables, Florida $30.7M AUM 111.27% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return

Aviva Holdings's Q1 2017 Portfolio in Review

As of Q1 2017, Aviva Holdings held 4 positions worth $214M, up 107% from $104M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Aviva Holdings deployed $93.4M of net new capital in Q1 2017, opening 2 new positions and adding to 1 existing holding. Its largest new stake was Medicines Co: 3,833,899 shares worth $187M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 9.1% a quarter earlier.

  • Aviva Holdings's largest Q1 2017 buy was Medicines Co: 3,833,899 shares worth $187M.
  • Aviva Holdings added most to Mirati Therapeutics, Inc. Common Stock in Q1 2017, an estimated $4.87M increase.
  • Aviva Holdings's ten largest holdings make up 100% of its $214M portfolio in Q1 2017.
  • Aviva Holdings opened 2 new positions and closed 1 in Q1 2017.
  • Aviva Holdings's portfolio value rose 107% quarter-over-quarter to $214M.

Based on Aviva Holdings's 13F filing for Q1 2017, filed 15 May 2017.